[
  {
    "ts": "2025-11-13T08:16:06+00:00",
    "headline": "What Catalysts Could Shift the Narrative for HCA Healthcare Stock?",
    "summary": "HCA Healthcare stock has seen a modest bump in analyst price targets, with the consensus estimate rising from $471 to approximately $476.67 per share. This upward adjustment follows strong quarterly performance and improving payment trends noted by the analyst community. Stay tuned to discover how investors can monitor shifts in sentiment and keep ahead of changes in the stock’s outlook going forward. Analyst Price Targets don't always capture the full story. Head over to our Company Report...",
    "url": "https://finance.yahoo.com/news/catalysts-could-shift-narrative-hca-081606828.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ab79cf8f-41e5-3b01-9171-767556a0e787",
      "content": {
        "id": "ab79cf8f-41e5-3b01-9171-767556a0e787",
        "contentType": "STORY",
        "title": "What Catalysts Could Shift the Narrative for HCA Healthcare Stock?",
        "description": "",
        "summary": "HCA Healthcare stock has seen a modest bump in analyst price targets, with the consensus estimate rising from $471 to approximately $476.67 per share. This upward adjustment follows strong quarterly performance and improving payment trends noted by the analyst community. Stay tuned to discover how investors can monitor shifts in sentiment and keep ahead of changes in the stock’s outlook going forward. Analyst Price Targets don't always capture the full story. Head over to our Company Report...",
        "pubDate": "2025-11-13T08:16:06Z",
        "displayTime": "2025-11-13T08:16:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d812e62bf7e6bf41872f387b852a9857",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ngo0QwEGQIhqHtymPMGDuQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d812e62bf7e6bf41872f387b852a9857.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w6BBB5qXo7j35i5uRonzOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d812e62bf7e6bf41872f387b852a9857.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/catalysts-could-shift-narrative-hca-081606828.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/catalysts-could-shift-narrative-hca-081606828.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HCA"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]